Transfusion Medicine Reviews
Volume 23, Issue 4 , Pages 292-309 , October 2009

Blood Group Antigens and Normal Red Blood Cell Physiology: A Canadian Blood Services Research and Development Symposium

References 

  1. Steinberg MH, Benz EJ, Adewoye HA, et al. Pathobiology of the human RBC and its hemoglobins. In:  Hoffman R,  Benz JR,  Shattil SJ,  Furie B,  Cohen HJ,  Silberstein LE,  McGlave P editor. Hoffman: Hematology: Basic Principles and Practice. ed 4. Orlando: Churchill Livingstone; 2005;p. 495–518
  2. Dessypris EN, Sawyer ST. Erythropoiesis. In:  Greer JP,  Foerster J,  Lukens JN,  Rodgers GM,  Paraskevas F,  Blader B editor. Wintrobe's Clinical Hematology. ed 11. Philadelphia: Lippincott Williams & Wilkins; 2003;p. 195–216
  3. Telen MJ, Kaufman RE. The mature erythrocyte. In:  Greer JP,  Foerster J,  Lukens JN,  Rodgers GM,  Paraskevas F,  Blader B editor. Wintrobe's Clinical Hematology. ed 11. Philadelphia: Lippincott Williams & Wilkins; 2003;p. 217–247
  4. Glader B. Destruction of erythrocytes. In:  Greer JP,  Foerster J,  Lukens JN,  Rodgers GM,  Paraskevas F,  Blader B editor. Wintrobe's Clinical Hematology. ed 11. Philadelphia: Lippincott Williams & Wilkins; 2003;p. 249–265
  5. Sawada K, Krantz SB, Dai CH, et al. Purification of human blood burst-forming units–erythroid and demonstration of the evolution of erythropoietin receptors. J Cell Physiol. 1990;142:219–230
  6. Krantz SB. Erythropoietin. Blood. 1991;77:419–434
  7. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science. 1990;248:378–381
  8. Bunn HF, May MH, Kocholaty WF, et al. Hemoglobin function in stored blood. J Clin Invest. 1969;48:311–321
  9. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA. 1993;269:3024–3029
  10. Gow AJ, Stamler JS. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature. 1998;391:169–173
  11. Natanson C, Kern SJ, Lurie P, et al. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: A meta-analysis. JAMA. 2008;299:2304–2312
  12. Murphy JR. RBC metabolism: I. The equilibration of glucose-C14 between serum and RBCs. J Lab Clin Med. 1960;55:281–285
  13. Murphy JR. RBC metabolism: II. Glucose metabolism and pathways. J Lab Clin Med. 1960;55:286–302
  14. An X, Mohandas N. Disorders of red cell membrane. Br J Haematol. 2008;141:367–375
  15. Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human RBCs. Arch Biochem Biophys. 1963;100:119–130
  16. Storry JR. Review: The function of blood group-specific RBC membrane components. Immunohematology. 2004;20:206–216
  17. Seidler NW, Swislocki NI. Ca2+ transport activities of inside-out vesicles prepared from density-separated RBCs from rat and human. Mol Cell Biochem. 1991;105:159–169
  18. Samaja M, Rubinacci A, Motterlini R, et al. Red cell aging and active calcium transport. Exp Gerontol. 1990;25:279–286
  19. Anderson DR, Davis JL, Carraway KL. Calcium-promoted changes of the human RBC membrane. Involvement of spectrin, transglutaminase, and a membrane-bound protease. J Biol Chem. 1977;252:6617–6623
  20. Aminoff D. The role of sialoglycoconjugates in the aging and sequestration of red cells from circulation. Blood Cells. 1988;14:229–257
  21. Pantaleo A, Giribaldi G, Mannu F, et al. Naturally occurring anti-band 3 antibodies and red blood cell removal under physiological and pathological conditions. Autoimmun Rev. 2008;7:457–462
  22. Jarolim P, Rubin HL, Zakova D, et al. Characterization of seven low incidence blood group antigens carried by RBC band 3 protein. Blood. 1998;92:4836–4843
  23. Shayakul C, Jarolim P, Zachlederova M, et al. Characterization of a highly polymorphic marker adjacent to the SLC4A1 gene and of kidney immunostaining in a family with distal renal tubular acidosis. Nephrol Dial Transplant. 2004;19:371–379
  24. Rysava R, Tesar V, Jirsa M, et al. Incomplete distal renal tubular acidosis coinherited with a mutation in the band 3 (AE1) gene. Nephrol Dial Transplant. 1997;12:1869–1873
  25. Bruce LJ. Red cell membrane transport abnormalities. Curr Opin Hematol. 2008;15:184–190
  26. Brabec V, Cermák J, Jarolím P. Silent forms of hereditary spherocytosis. Vnitr Lek. 1999;45:594–597
  27. Brabec V, Palek J, Petrtýlová K, et al. Relation between types of RBC membrane defects and the clinical picture in hereditary spherocytosis. Vnitr Lek. 1997;43:91–94
  28. Hassoun H, Vassiliadis JN, Murray J, et al. Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency. Blood. 1997;90:398–406
  29. Jarolim P, Murray JL, Rubin HL, et al. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood. 1996;88:4366–4374
  30. Delaunay J. Red cell membrane and erythropoiesis genetic defects. Hematol J. 2003;4:225–232
  31. Bruce LJ, Robinson HC, Guizouarn H, et al. Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE1. Nat Genet. 2005;37:1258–1263
  32. Bruce L. Mutations in band 3 and cation leaky red cells. Blood Cells Mol Dis. 2006;36:331–336
  33. O'Donnell A, Raiko A, Clegg JB, et al. Southeast Asian ovalocytosis and pregnancy in a malaria-endemic region of Papua New Guinea. Am J Trop Med Hyg. 2007;76:631–633
  34. Kuma H, Abe Y, Askin D, et al. Molecular basis and functional consequences of the dominant effects of the mutant band 3 on the structure of normal band 3 in Southeast Asian ovalocytosis. Biochem. 2002;41:3311–3320
  35. Kimura M, Soemantri A, Ishida T. Malaria species and Southeast Asian ovalocytosis defined by a 27-bp deletion in the RBC band 3 gene. Southeast Asian J Trop Med Public Health. 2002;33:4–6
  36. Patel SS, King CL, Mqone CS, et al. Glycophorin C (Gerbich antigen blood group) and band 3 polymorphisms in two malaria holoendemic regions of Papua New Guinea. Am J Hematol. 2004;75:1–5
  37. Allen SJ, O’Donnell A, Alexander ND, et al. Prevention of cerebral malaria in children in Papua New Guinea by Southeast Asian ovalocytosis band 3. Am J Trop Med Hygiene. 1999;60:1056–1060
  38. Paw BH, Davidson AJ, Zhou Y, et al. Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency. Nat Genet. 2003;34:59–64
  39. Jarolim P, Kalábová D, Reid ME. Substitution Glu480Lys in erythroid band 3 corresponds to the Fr(a) blood group antigen and supports existence of the second ectoplasmic loop of band 3. Transfusion. 2004;44:684–689
  40. Jarolim P, Murray JL, Rubin HL, et al. Blood group antigens Rb(a), Tr(a), and Wd(a) are located in the third ectoplasmic loop of erythroid band 3. Transfusion. 1997;37:607–615
  41. Cartron JP. Blood group antigens structure and function: Recent advances. Hematology Education: The Education Program for the Annual Congress of the European Hematology Association. 2008;2:158–174
  42. Cartron JP. Rh blood group system and molecular basis of Rh-deficiency. Baillieres Best Pract Res Clin Haematol. 1999;12:655–689
  43. Mouro-Chanteloup I, D'Ambrosio AM, Gane P, et al. Cell-surface expression of RhD blood group polypeptide is posttranscriptionally regulated by the RhAG glycoprotein. Blood. 2002;100:1038–1047
  44. Nicolas V, Le Van Kim C, Gane P, et al. Rh-RhAG/ankyrin-R, a new interaction site between the membrane bilayer and the red cell skeleton, is impaired by Rh(null)-associated mutation. J Biol Chem. 2003;278:25526–25533
  45. Marini AM, Urrestarazu A, Beauwens R, et al. The Rh (rhesus) blood group polypeptides are related to NH4+ transporters. Trends Biochem Sci. 1997;22:460–461
  46. Marini AM, Matassi G, Raynal V, et al. The human Rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast. Nat Genet. 2000;26:341–344
  47. Goossens D, bony V, Gane P, et al. Generation of mice with inactivated Rh or RhAG genes. Transfus Clin Biol. 2006;13:164–166
  48. Ripoche P, Bertrand O, Gane P, et al. Human Rhesus-associated glycoprotein mediates facilitated transport of NH(3) into red blood cells. Proc Natl Acad Sci U S A. 2004;101:17222–17227
  49. Khademi S, O'Connell J, Remis J, et al. Mechanism of ammonia transport by Amt/MEP/Rh: structure of AmtB at 1.35 A. Science. 2004;305:1587–1594
  50. Lupo D, Li XD, Durand A, et al. The 1.3-A resolution structure of Nitrosomonas europaea Rh50 and mechanistic implications for NH3 transport by Rhesus family proteins. Proc Natl Acad Sci U S A. 2007;104:19303–19308
  51. Callebaut I, Dulin F, Bertrand O, et al. Hydrophobic cluster analysis and modeling of the human Rh protein three-dimensional structures. Transfus Clin Biol. 2006;13:70–84
  52. Huang CH, Peng J. Evolutionary conservation and diversification of Rh family genes and proteins. Proc Natl Acad Sci U S A. 2005;102:15512–15517
  53. Soupene E, King N, Field E, et al. Rhesus expression in a green alga is regulated by CO(2). Proc Natl Acad Sci U S A. 2002;99:7769–7773
  54. Soupene E, Inwood W, Kustu S. Lack of the Rhesus protein Rh1 impairs growth of the green alga Chlamydomonas reinhardtii at high CO2. Proc Natl Acad Sci U S A. 2004;101:7787–7792
  55. Endeward V, Cartron JP, Ripoche P, et al. RhAG protein of the Rhesus complex is a CO2 channel in the human red cell membrane. FASEB J. 2008;22:64–73
  56. Li X, Jayachandran S, Nguyen HH, et al. Structure of the Nitrosomonas europaea Rh protein. Proc Natl Acad Sci U S A. 2007;104:19279–19284
  57. Reviron D, Dettori I, Ferrera V, et al. HLA-DRB1 alleles and Jk(a) immunization. Transfusion. 2005;45:956–959
  58. Heaton DC, McLoughlin K. Jk(a−b−) red blood cells resist urea lysis. Transfusion. 1982;22:70–71
  59. Fröhlich O, Macey RI, Edwards-Moulds J, et al. Urea transport deficiency in Jk(a−b−) RBCs. Am J Physiol. 1991;260(4 Pt 1):C778–C783
  60. Sands JM, Gargus JJ, Fröhlich O, et al. Urinary concentrating ability in patients with Jk(a−b−) blood type who lack carrier-mediated urea transport. Am J Physiol. 1992;2:1689–1696
  61. You G, Smith CP, Kanai Y, et al. Cloning and characterization of the vasopressin-regulated urea transporter. Nature. 1993;365:844–847
  62. Olives B, Neau P, Bailly P, et al. Cloning and functional expression of a urea transporter from human bone marrow cells. J Biol Chem. 1994;269:31649–31652
  63. Lucien N, Sidoux-Walter F, Roudier N, et al. Antigenic and functional properties of the human red blood cell urea transporter hUT-B1. J Biol Chem. 2002;277:34101–34108
  64. Olivès B, Martial S, Mattei MG, et al. Molecular characterization of a new urea transporter in the human kidney. FEBS Lett. 1996;386:156–160
  65. Lerut E, Van Damme B, Noizat-Pirenne F, et al. Duffy and Kidd blood group antigens: Minor histocompatibility antigens involved in renal allograft rejection?. Transfusion. 2007;47:28–40
  66. Macey RI, Farmer RE. Inhibition of water and solute permeability in human red cells. Biochim Biophys Acta. 1970;211:104–106
  67. Olivès B, Mattei MG, Huet M, et al. Kidd blood group and urea transport function of human RBCs are carried by the same protein. J Biol Chem. 1995;270:15607–15610
  68. Yang B, Verkman AS. Analysis of double knockout mice lacking aquaporin-1 and urea transporter UT-B. Evidence for UT-B-facilitated water transport in RBCs. J Biol Chem. 2002;277:36782–36786
  69. Yang B, Bankir L, Gillespie A, et al. Urea-selective concentrating defect in transgenic mice lacking urea transporter UT-B. J Biol Chem. 2002;277:10633–10637
  70. Uchida S, Sohara E, Rai T, et al. Impaired urea accumulation in the inner medulla of mice lacking the urea transporter UT-A2. Mol Cell Biol. 2005;25:7357–7363
  71. Fenton RA, Chou CL, Stewart GS, et al. Urinary concentrating defect in mice with selective deletion of phloretin-sensitive urea transporters in the renal collecting duct. Proc Natl Acad Sci U S A. 2004;101:7469–7474
  72. Rettig MP, Low PS, Gimm JA, et al. Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog. Blood. 1999;93:376–384
  73. Kay MM, Bosman GJ, Johnson GJ, et al. Band-3 polymers and aggregates, and hemoglobin precipitates in red cell aging. Blood Cells. 1998;14:275–295
  74. Kay MM. Isolation of the phagocytosis-inducing IgG-binding antigen on senescent somatic cells. Nature. 1981;289:491–494
  75. Kay MM, Goodman SR, Sorensen K, et al. Senescent cell antigen is immunologically related to band 3. Proc Natl Acad Sci U S A. 1983;80:1631–1635
  76. Kay MM. Localization of senescent cell antigen on band 3. Proc Natl Acad Sci U S A. 1984;81:5753–5757
  77. Kay MM, Marchalonis JJ, Hughes J, et al. Definition of a physiologic aging autoantigen by using synthetic peptides of membrane protein band 3: Localization of the active antigenic sites. Proc Natl Acad Sci U S A. 1990;87:5734–5738
  78. Branch DR, Shulman IA, Sy Siok Hian AL, et al. Two distinct categories of warm autoantibody reactivity with age-fractionated red cells. Blood. 1984;63:177–180
  79. Kay MM, Flowers N, Goodman J, et al. Alteration in membrane protein band 3 associated with accelerated RBC aging. Proc Natl Acad Sci U S A. 1989;86:5834–5838
  80. Barker RN, Shen CR, Elson CJ. T-cell specificity in murine autoimmune haemolytic anaemia induced by rat red blood cells. Clin Exp Immunol. 2002;129:208–213
  81. Kay MM. Aging of cell membrane molecules leads to appearance of an aging antigen and removal of senescent cells. Gerontology. 1985;31:215–235
  82. Kay MM, Bosman GJ, Shapiro SS, et al. Oxidation as a possible mechanism of cellular aging: Vitamin E deficiency causes premature aging and IgG binding to RBCs. Proc Natl Acad Sci U S A. 1986;83:2463–2467
  83. Low PS, Waugh SM, Zinke K, et al. The role of hemoglobin denaturation and band 3 clustering in red blood cell aging. Science. 1985;227:531–533
  84. Kriebardis AG, Antonelou MH, Stamoulis KE, et al. Storage-dependent remodeling of the red blood cell membrane is associated with increased immunoglobulin G binding, lipid raft rearrangement, and caspase activation. Transfusion. 2007;47:1212–1220

 This conference, the sixth annual CBS R&D international symposium, took place at the University of Toronto in Toronto, Ontario, Canada, on September 27, 2008, and was chaired by Dr Donald R. Branch, R&D Scientist, Canadian Blood Services, and associate professor of medicine, University of Toronto.

PII: S0887-7963(09)00057-1

doi: 10.1016/j.tmrv.2009.06.004

Transfusion Medicine Reviews
Volume 23, Issue 4 , Pages 292-309 , October 2009

Article Tools

* Image Usage & Resolution